BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22972171)

  • 1. Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysis.
    Kamada Y; Sakata-Yanagimoto M; Sanada M; Sato-Otsubo A; Enami T; Suzukawa K; Kurita N; Nishikii H; Yokoyama Y; Okoshi Y; Hasegawa Y; Ogawa S; Chiba S
    Int J Hematol; 2012 Oct; 96(4):492-500. PubMed ID: 22972171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value.
    Walker BA; Leone PE; Chiecchio L; Dickens NJ; Jenner MW; Boyd KD; Johnson DC; Gonzalez D; Dagrada GP; Protheroe RK; Konn ZJ; Stockley DM; Gregory WM; Davies FE; Ross FM; Morgan GJ
    Blood; 2010 Oct; 116(15):e56-65. PubMed ID: 20616218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect.
    Agnelli L; Mosca L; Fabris S; Lionetti M; Andronache A; Kwee I; Todoerti K; Verdelli D; Battaglia C; Bertoni F; Deliliers GL; Neri A
    Genes Chromosomes Cancer; 2009 Jul; 48(7):603-14. PubMed ID: 19396863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics of multiple myeloma.
    Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
    Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.
    Carballo-Zarate AA; Medeiros LJ; Fang L; Shah JJ; Weber DM; Thomas SK; Manasanch EE; Hao S; Shen Q; Orlowski RZ; Lin P; Lu X
    Mod Pathol; 2017 Jun; 30(6):843-853. PubMed ID: 28281554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
    Sawyer JR
    Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis.
    Purdie KJ; Lambert SR; Teh MT; Chaplin T; Molloy G; Raghavan M; Kelsell DP; Leigh IM; Harwood CA; Proby CM; Young BD
    Genes Chromosomes Cancer; 2007 Jul; 46(7):661-9. PubMed ID: 17420988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.
    Okamoto R; Ogawa S; Nowak D; Kawamata N; Akagi T; Kato M; Sanada M; Weiss T; Haferlach C; Dugas M; Ruckert C; Haferlach T; Koeffler HP
    Haematologica; 2010 Sep; 95(9):1481-8. PubMed ID: 20435627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
    Lee JW; Lee JK; Hong YJ; Hong SI; Chang YH
    Korean J Lab Med; 2008 Dec; 28(6):413-8. PubMed ID: 19127104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of single nucleotide polymorphism array in prenatal diagnosis for fetuses with abnormal ultrasound findings].
    Guo YL; Wang L; Xue SW; Qu SZ; Yang J; Xu H; Bai ZX; Liu N; Kong XD
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):464-470. PubMed ID: 30078256
    [No Abstract]   [Full Text] [Related]  

  • 11. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.
    Hagenkord JM; Monzon FA; Kash SF; Lilleberg S; Xie Q; Kant JA
    J Mol Diagn; 2010 Mar; 12(2):184-96. PubMed ID: 20075210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress of Clinical Application of SNP-A to MDS--Review].
    Chi K; Jing XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1244-1247. PubMed ID: 30111439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.
    Wu KL; Beverloo B; Velthuizen SJ; Sonneveld P
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):280-5. PubMed ID: 17324335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia.
    Huh J; Jung CW; Kim JW; Kim HJ; Kim SH; Shin MG; Kim YK; Kim HJ; Suh JS; Moon JH; Sohn SK; Nam GH; Lee JE; Kim DH
    Ann Hematol; 2011 Nov; 90(11):1255-64. PubMed ID: 21384125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic aberrations revealed exclusively by single nucleotide polymorphism (SNP) genotyping data in 5000 samples tested by molecular karyotyping.
    Bruno DL; White SM; Ganesamoorthy D; Burgess T; Butler K; Corrie S; Francis D; Hills L; Prabhakara K; Ngo C; Norris F; Oertel R; Pertile MD; Stark Z; Amor DJ; Slater HR
    J Med Genet; 2011 Dec; 48(12):831-9. PubMed ID: 22039585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic abnormalities in high-risk multiple myeloma].
    Ishida T
    Nihon Rinsho; 2015 Jan; 73(1):28-32. PubMed ID: 25626299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma.
    Chillón MC; Jiménez C; García-Sanz R; Alcoceba M; Prieto I; García-Alvarez M; Antón A; Maldonado R; Hernández-Ruano M; González M; Gutiérrez NC; Sarasquete ME
    Ann Hematol; 2017 Oct; 96(10):1699-1705. PubMed ID: 28770277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore.
    Lim AS; Lim TH; See KH; Ng YJ; Tan YM; Choo NS; Lim SX; Yee Y; Lau LC; Tien SL; Sathish K; Tan DC
    Chin Med J (Engl); 2013; 126(10):1872-7. PubMed ID: 23673102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience.
    Smetana J; Frohlich J; Zaoralova R; Vallova V; Greslikova H; Kupska R; Nemec P; Mikulasova A; Almasi M; Pour L; Adam Z; Sandecka V; Zahradová L; Hajek R; Kuglik P
    Biomed Res Int; 2014; 2014():209670. PubMed ID: 24987674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.